Longyan Yang

1.2k total citations
70 papers, 837 citations indexed

About

Longyan Yang is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Longyan Yang has authored 70 papers receiving a total of 837 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Cardiology and Cardiovascular Medicine, 22 papers in Molecular Biology and 17 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Longyan Yang's work include Lipid metabolism and disorders (16 papers), Liver Disease Diagnosis and Treatment (10 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (10 papers). Longyan Yang is often cited by papers focused on Lipid metabolism and disorders (16 papers), Liver Disease Diagnosis and Treatment (10 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (10 papers). Longyan Yang collaborates with scholars based in China, United States and Saudi Arabia. Longyan Yang's co-authors include Dong Zhao, Ruili Yin, Lijie Zhang, Yongsong Xu, Yuanyuan Zhang, Junqi He, Dong Zhao, Jing Ke, Duiping Feng and Yan Ma and has published in prestigious journals such as Diabetes, Scientific Reports and Biochemical Journal.

In The Last Decade

Longyan Yang

62 papers receiving 832 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Longyan Yang China 19 323 218 172 145 122 70 837
Meimei Yin United States 15 434 1.3× 155 0.7× 152 0.9× 70 0.5× 103 0.8× 21 1.1k
Yi Fu China 17 329 1.0× 130 0.6× 63 0.4× 155 1.1× 77 0.6× 44 898
Lu Gao China 20 599 1.9× 90 0.4× 246 1.4× 135 0.9× 171 1.4× 63 1.2k
Miriam Lee‐Rueckert Finland 22 315 1.0× 204 0.9× 135 0.8× 187 1.3× 112 0.9× 42 996
Xiaokun Wang China 15 350 1.1× 99 0.5× 64 0.4× 146 1.0× 273 2.2× 53 878
Shyam Sundar Nandi United States 17 365 1.1× 82 0.4× 218 1.3× 140 1.0× 81 0.7× 44 796
Gang Ren China 17 686 2.1× 214 1.0× 257 1.5× 412 2.8× 91 0.7× 51 1.4k
Julie Nigro Australia 16 416 1.3× 165 0.8× 115 0.7× 81 0.6× 102 0.8× 28 954
Xian Jin China 14 569 1.8× 95 0.4× 159 0.9× 229 1.6× 147 1.2× 31 1.1k
Shuya Wang China 14 381 1.2× 191 0.9× 69 0.4× 91 0.6× 110 0.9× 32 753

Countries citing papers authored by Longyan Yang

Since Specialization
Citations

This map shows the geographic impact of Longyan Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Longyan Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Longyan Yang more than expected).

Fields of papers citing papers by Longyan Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Longyan Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Longyan Yang. The network helps show where Longyan Yang may publish in the future.

Co-authorship network of co-authors of Longyan Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Longyan Yang. A scholar is included among the top collaborators of Longyan Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Longyan Yang. Longyan Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Yan, Ruili Yin, Yongsong Xu, et al.. (2025). Reduced expression of PDZK1 mediates fibroblast activation and cardiac fibrosis via EGFR phosphorylation in diabetic cardiomyopathy. Life Sciences. 379. 123916–123916.
2.
Chen, Chenglizhao, et al.. (2025). A Comprehensive Survey on 3D Single-View Object Reconstruction. IEEE Transactions on Visualization and Computer Graphics. 31(10). 9502–9521.
3.
Yang, Longyan, Xinyu Li, Yi Zhang, Pengfei Yin, & Xiyuan Sun. (2024). DFT-D3 and TD-DFT studies on the sensor performance of the functionalized carbon quantum dots for curcumin. Surfaces and Interfaces. 45. 103870–103870. 8 indexed citations
4.
5.
Ke, Jing, et al.. (2024). The Effect of Canagliflozin on High‐Density Lipoprotein Cholesterol and Angiopoietin‐Like Protein 3 in Type 2 Diabetes Mellitus. Journal of Diabetes Research. 2024(1). 2431441–2431441. 2 indexed citations
6.
Zhao, Hongling, Ruili Yin, Yan Wang, et al.. (2024). Association between blood heavy metals and diabetic kidney disease among type 2 diabetic patients: a cross-sectional study. Scientific Reports. 14(1). 26823–26823.
7.
Chen, Baiyu, Zhilei Chen, Mei He, et al.. (2024). Recent advances in the role of mesenchymal stem cells as modulators in autoinflammatory diseases. Frontiers in Immunology. 15. 1525380–1525380. 7 indexed citations
8.
Zhang, Lijie, et al.. (2024). Gestational diabetes mellitus affects the differentiation of hematopoietic stem cells in neonatal umbilical cord blood. Archives of Gynecology and Obstetrics. 310(2). 1109–1119. 1 indexed citations
9.
Li, Kun, Cai‐Guo Yu, Ruili Yin, et al.. (2024). Angiopoietin‐like 4 is a potential biomarker for diabetic kidney disease in type 2 diabetes patients. Journal of Diabetes Investigation. 15(12). 1763–1772. 1 indexed citations
10.
Yang, Longyan, Yongsong Xu, Kun Li, et al.. (2024). ANGPTL3 is a novel HDL component that regulates HDL function. Journal of Translational Medicine. 22(1). 263–263. 6 indexed citations
11.
Yang, Longyan, Qaiser Shakeel, Xueqin Xu, et al.. (2024). Optimized submerged batch fermentation for metabolic switching in Streptomyces yanglinensis 3–10 providing platform for reveromycin A and B biosynthesis, engineering, and production. Frontiers in Microbiology. 15. 1378834–1378834. 3 indexed citations
12.
Wang, Yan, Ruili Yin, Yongsong Xu, et al.. (2023). Central role of cardiac fibroblasts in myocardial fibrosis of diabetic cardiomyopathy. Frontiers in Endocrinology. 14. 1162754–1162754. 33 indexed citations
13.
Wu, Jianbo, Yunkun Dang, Fan Lai, et al.. (2023). The Metabolism and Immune Environment in Diffuse Large B-Cell Lymphoma. Metabolites. 13(6). 734–734. 5 indexed citations
14.
Wei, Lingling, Yongsong Xu, Lijie Zhang, et al.. (2022). Mesenchymal Stem Cells Promote Wound Healing and Effects on Expression of Matrix Metalloproteinases-8 and 9 in the Wound Tissue of Diabetic Rats. Stem Cells and Development. 32(1-2). 25–31. 15 indexed citations
15.
Yin, Ruili, Yan Ma, Ning Zhang, Longyan Yang, & Dong Zhao. (2022). Combined Effects of Voluntary Running and Liraglutide on Glucose Homeostasis, Fatty Acid Composition of Brown Adipose Tissue Phospholipids, and White Adipose Tissue Browning in Db/Db Mice. The Chinese Journal of Physiology. 65(3). 117–124. 5 indexed citations
16.
Zhang, Yuanyuan, et al.. (2022). Epigallocatechin-3-gallate ameliorates hepatic damages by relieve FGF21 resistance and promotion of FGF21–AMPK pathway in mice fed a high fat diet. Diabetology & Metabolic Syndrome. 14(1). 53–53. 16 indexed citations
17.
Ke, Jing, et al.. (2021). Relationship of Para and Perirenal Fat and High-Density Lipoprotein and Its Function in Patients with Type 2 Diabetes Mellitus. International Journal of Endocrinology. 2021. 1–7. 8 indexed citations
18.
Yin, Ruili, Xiaojing Wang, Kun Li, Ke Yu, & Longyan Yang. (2021). Lipidomic profiling reveals distinct differences in plasma lipid composition in overweight or obese adolescent students. BMC Endocrine Disorders. 21(1). 201–201. 19 indexed citations
19.
Yu, Cai‐Guo, Ning Zhang, Yan Ma, et al.. (2016). Endothelial Progenitor Cells in Diabetic Microvascular Complications: Friends or Foes?. Stem Cells International. 2016(1). 1803989–1803989. 27 indexed citations
20.
Cheng, Shan, Yang Li, Ying Yang, et al.. (2013). Breast cancer‐derived K172N, D301V mutations abolish Na+/H+ exchanger regulatory factor 1 inhibition of platelet‐derived growth factor receptor signaling. FEBS Letters. 587(20). 3289–3295. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026